HealthQuill Articles by: HealthQuill
India's Glenmark Pharmaceuticals has got the final approval by the USFDA for its generic prochlorperazine maleate tablets, the generic version of compazine of GlaxoSmithKline.
Drugs Medical Pharma

Glenmark’s drug to treat nausea, psychosis gets FDA nod

India's Glenmark Pharmaceuticals has got the final approval by the USFDA for its generic prochlorperazine maleate tablets, the generic version of compazine of

Read More
Eli Lilly announced that it had received US FDA approval for a tablet to treat a rare form of blood cancer.
Drugs Health Medical Pharma

FDA panel votes for full approval of Pfizer’s covid pill Paxlovid

The FDA’s advisory panel recommended full approval of Pfizer’s Covid antiviral treatment Paxlovid for high-risk adults.

Read More
The WHO slammed the Chinese authorities for not being transparent in sharing data related to COVID-19 origins and urged Beijing to conduct "investigations and share the results" with the global health agency.
Drugs Health Medical Pharma

New report opens a can of worms on COVID-19 origins, WHO steps in

The WHO slammed the Chinese authorities for not being transparent in sharing data related to COVID-19 origins and urged Beijing to conduct "investigations

Read More
Lupin Digital Health, a fully-owned subsidiary of Lupin, stated 83.3% of study patients with the acute coronary syndrome (ACS) maintained their vital signs in a programme aimed at valuing the efficacy of its Lyfe digital therapeutical platform.
Drugs Health Pharma

83.3% ACS patients achieve normality: Lupin Digital Health study

Lupin Digital Health, a fully-owned subsidiary of Lupin, stated 83.3% of study patients with the acute coronary syndrome (ACS) maintained their vital signs

Read More
Jubilant HollisterStier, a subsidiary of India's Jubilant Pharmova, has got Canada's nod for a partially repayable loan of CAD 23.8 million ($17.7 million) for expansion in Montreal.
Drugs Medical Pharma

Jubilant HollisterStier gets $17.7 million Canadian funding

Jubilant HollisterStier, a subsidiary of India's Jubilant Pharmova, has got Canada's nod for a partially repayable loan of CAD 23.8 million ($17.7 million)

Read More
Sanofi, a French pharmaceutical major, announced it would slash the price of insulin, Lantus, by 78% for all U.S. patients with commercial insurance.
Drugs Medical Pharma

Sanofi lowers Lantus insulin costs by 78% in U.S. market

Sanofi, a French pharmaceutical major, announced it would slash the price of insulin, Lantus, by 78% for all U.S. patients with commercial insurance.

Read More
Glenmark Specialty SA, a subsidiary of India’s Glenmark Pharmaceuticals, has got investigational new drug clearance from the FDA to conduct clinical trials in the US sites for its drug to treat advanced solid tumours and lymphomas.
Drugs Medical Pharma

Glenmark gets FDA nod for trials in US on tumour, cancer patients

Glenmark Specialty SA, a subsidiary of India’s Glenmark Pharmaceuticals, has got investigational new drug clearance from the FDA to conduct clinical trials in

Read More
fibrosis therapy pact
Medical Pharma

Mediar bags $105 mn from big pharmas to pursue fibrosis treatments

Mediar Therapeutics gets $105 million financing from Novartis, Pfizer, Eli Lilly and Bristol Myers to advance portfolio of first-in-class fibrosis therapies.

Read More
India's Dr. Reddy's Laboratories has divested "certain" non-core dermatology brands of the company to Eris Lifesciences for INR 2.7 billion.
Drugs Pharma

Dr. Reddy divests dermatology brands to Eris for INR 2.7b

India's Dr. Reddy's Laboratories has divested "certain" non-core dermatology brands of the company to Eris Lifesciences for INR 2.7 billion.

Read More
Janssen Pharmaceutical Companies, a wholly-owned subsidiary of Johnson & Johnson, announced its first-in-human clinical trial of a compound to treat dengue had entered the second phase.
Drugs Pharma

Janssen’s human trials for dengue virus to advance to phase II

Janssen Pharmaceutical Companies, a wholly-owned subsidiary of Johnson & Johnson, announced its first-in-human clinical trial of a compound to treat dengue had entered

Read More